51 related articles for article (PubMed ID: 21550659)
21. Prognostic significance of PRAME expression based on immunohistochemistry for diffuse large B-cell lymphoma patients treated with R-CHOP therapy.
Mitsuhashi K; Masuda A; Wang YH; Shiseki M; Motoji T
Int J Hematol; 2014 Jul; 100(1):88-95. PubMed ID: 24820636
[TBL] [Abstract][Full Text] [Related]
22. Elevated PRAME expression: what does this mean for treatment of head and neck squamous cell carcinoma?
Szczepanski MJ; Whiteside TL
Biomark Med; 2013 Aug; 7(4):575-8. PubMed ID: 23905893
[No Abstract] [Full Text] [Related]
23. Genome-wide promoter methylation profile of human testis and epididymis: identified from cell-free seminal DNA.
Wu C; Ding X; Li H; Zhu C; Xiong C
BMC Genomics; 2013 Apr; 14():288. PubMed ID: 23622456
[TBL] [Abstract][Full Text] [Related]
24. The human EKC/KEOPS complex is recruited to Cullin2 ubiquitin ligases by the human tumour antigen PRAME.
Costessi A; Mahrour N; Sharma V; Stunnenberg R; Stoel MA; Tijchon E; Conaway JW; Conaway RC; Stunnenberg HG
PLoS One; 2012; 7(8):e42822. PubMed ID: 22912744
[TBL] [Abstract][Full Text] [Related]
25. PRAME promotes in vitro leukemia cells death by regulating S100A4/p53 signaling.
Xu Y; Rong LJ; Meng SL; Hou FL; Zhang JH; Pan G
Eur Rev Med Pharmacol Sci; 2016; 20(6):1057-63. PubMed ID: 27049257
[TBL] [Abstract][Full Text] [Related]
26. Expression and prognostic relevance of PRAME in primary osteosarcoma.
Tan P; Zou C; Yong B; Han J; Zhang L; Su Q; Yin J; Wang J; Huang G; Peng T; Shen J
Biochem Biophys Res Commun; 2012 Mar; 419(4):801-8. PubMed ID: 22390931
[TBL] [Abstract][Full Text] [Related]
27. Silencing HCCR2 expression inhibits the proliferation of leukemia cells by inducing apoptosis and promoting cell cycle arrest.
Qiao SK; Ren HY; Shi YJ; Liu W
Int J Mol Med; 2013 Dec; 32(6):1373-9. PubMed ID: 24126909
[TBL] [Abstract][Full Text] [Related]
28. PRAME induces apoptosis and inhibits proliferation of leukemic cells in vitro and in vivo.
Xu Y; Yue Q; Wei H; Pan G
Int J Clin Exp Pathol; 2015; 8(11):14549-55. PubMed ID: 26823776
[TBL] [Abstract][Full Text] [Related]
29. PRAME-induced inhibition of retinoic acid receptor signaling-mediated differentiation--a possible target for ATRA response in AML without t(15;17).
Bullinger L; Schlenk RF; Götz M; Botzenhardt U; Hofmann S; Russ AC; Babiak A; Zhang L; Schneider V; Döhner K; Schmitt M; Döhner H; Greiner J
Clin Cancer Res; 2013 May; 19(9):2562-71. PubMed ID: 23444226
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of PRAME expression causes cell cycle arrest and apoptosis in leukemic cells.
Tanaka N; Wang YH; Shiseki M; Takanashi M; Motoji T
Leuk Res; 2011 Sep; 35(9):1219-25. PubMed ID: 21550659
[TBL] [Abstract][Full Text] [Related]
31. STAT3 inhibition as a therapeutic strategy for leukemia.
Kanna R; Choudhary G; Ramachandra N; Steidl U; Verma A; Shastri A
Leuk Lymphoma; 2018 Sep; 59(9):2068-2074. PubMed ID: 29164994
[TBL] [Abstract][Full Text] [Related]
32. Preferentially expressed antigen of melanoma (PRAME) in the development of diagnostic and therapeutic methods for hematological malignancies.
Matsushita M; Yamazaki R; Ikeda H; Kawakami Y
Leuk Lymphoma; 2003 Mar; 44(3):439-44. PubMed ID: 12688312
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]